BEGIN:VCALENDAR
PRODID:-//github.com/ical-org/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VTIMEZONE
TZID:America/New_York
X-LIC-LOCATION:America/New_York
BEGIN:STANDARD
DTSTART:20241103T020000
RRULE:FREQ=YEARLY;BYDAY=1SU;BYMONTH=11
TZNAME:EST
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20250309T020000
RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=3
TZNAME:EDT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DESCRIPTION:Breakthrough discoveries in neuroscience occur every day\, but
  identifying the findings most likely to translate into meaningful therap
 ies remains a challenge. Whether investigating novel targets\, exploring 
 disease mechanisms\, or evaluating emerging therapeutic approaches\, rese
 archers need access to connected and trustworthy scientific intelligence.
  Join this hands-on training session to learn how Cortellis Drug Discover
 y Intelligence brings together biological\, chemical\, pharmacological\, 
 and development data to help researchers navigate the rapidly evolving ne
 uroscience landscape. Through neuroscience-focused examples\, attendees w
 ill learn how to uncover emerging opportunities\, evaluate targets and pa
 thways\, benchmark therapeutic strategies\, and make more informed resear
 ch decisions. Teaching Goals 1. Discover the science behind emerging neur
 oscience targets Explore the biological evidence\, disease associations\,
  and pathway context supporting targets relevant to neurological and neur
 opsychiatric disorders. 2. Understand the therapeutic landscape Identify 
 who is developing what\, compare competing approaches\, and assess how di
 fferent mechanisms are being pursued across academia and industry. 3. Tur
 n data into research insights Learn how Cortellis Drug Discovery Intellig
 ence can support target validation\, hypothesis generation\, and strategi
 c decision-making during the early stages of drug discovery. Who should a
 ttend? Although we will use a neuroscience example\, any researcher invol
 ved in drug discovery\, target identification and validation\, disease bi
 ology\, translational science\, and competitive intelligence who want to 
 better understand emerging therapeutic opportunities and the evolving lan
 dscape will benefit from this training.\n\nSpeaker:\nNúria Forns Escudé\,
  PhD\n\nAdmission:\nFree\n\nDetails URL:\nhttps://medicine.yale.edu/event
 /whats-next-in-neuroscience-tubiological-insights-into-therapeutic-opport
 unities-with-cortellis-drug/\n
DTEND;TZID=America/New_York:20261105T110000
DTSTAMP:20261026T040913Z
DTSTART;TZID=America/New_York:20261105T100000
LOCATION:Registration is required\, visit RSVP link above for more event i
 nformation.
SEQUENCE:0
STATUS:Confirmed
SUMMARY:What's Next in Neuroscience? TuBiological Insights into Therapeuti
 c Opportunities with Cortellis Drug Discovery Intelligence
UID:099d6e80-c4a9-4a46-9e21-989fc9bae0bd
END:VEVENT
END:VCALENDAR